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Abstract
Background
An accurate and affordable CD4+ T cells count is an essential tool in the fight against HIV/
AIDS. Flow cytometry (FCM) is the “gold standard” for counting such cells, but this tech-
nique is expensive and requires sophisticated equipment, temperature-sensitive monoclo-
nal antibodies (mAbs) and trained personnel. The lack of access to technical support and
quality assurance programs thus limits the use of FCM in resource-constrained countries.
We have tested the accuracy, the precision and the carry-over contamination of Partec
CyFlow MiniPOC, a portable and economically affordable flow cytometer designed for
CD4+ count and percentage, used along with the “CD4% Count Kit-Dry”.
Materials and Methods
Venous blood from 59 adult HIV+ patients (age: 25–58 years; 43 males and 16 females)
was collected and stained with the “MiniPOC CD4% Count Kit-Dry”. CD4+ count and per-
centage were then determined in triplicate by the CyFlow MiniPOC. In parallel, CD4 count
was performed using mAbs and a CyFlow Counter, or by a dual platform system (from
Beckman Coulter) based upon Cytomic FC500 (“Cytostat tetrachrome kit” for mAbs) and
Coulter HmX Hematology Analyzer (for absolute cell count).
Results
The accuracy of CyFlow MiniPOC against Cytomic FC500 showed a correlation coefficient
(CC) of 0.98 and 0.97 for CD4+ count and percentage, respectively. The accuracy of
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CyFlow MiniPOC against CyFlow Counter showed a CC of 0.99 and 0.99 for CD4 T cell
count and percentage, respectively. CyFlow MiniPOC showed an excellent repeatability:
CD4+ cell count and percentage were analyzed on two instruments, with an intra-assay pre-
cision below ±5% deviation. Finally, there was no carry-over contamination for samples at
all CD4 values, regardless of their position in the sequence of analysis.
Conclusion
The cost-effective CyFlow MiniPOC produces rapid, reliable and accurate results that are
fully comparable with those from highly expensive dual platform systems.
Introduction
An estimated 35.3 (32.2–38.8) million people are living with human immunodeficiency virus
(HIV) [1]. The epidemics continues to disproportionately affect sub-Saharan Africa, home to
70% of all new HIV infections in 2012 [1]. Since the virus kills, directly or indirectly, CD4+
T cells [2, 3], the accurate, reliable, and affordable CD4+ T cell count is essential in determining
disease stage and progression [4]. An active monitoring of the immune system in both HIV pa-
tients and individuals who are regarded as “at-risk” is crucial in determining when antiretrovi-
ral therapy has to start, and in its monitoring [5, 6]. Moreover, although absolute CD4 counts
are used for assessing the clinical status and eventual progression of the infection in adult pa-
tients, populations of lymphocytes including CD4+ are greater in children. Therefore, in HIV+
children it is more informative to measure the percentage of CD4+ T cells among the total lym-
phocyte population [7].
Since the beginning of the epidemics, flow cytometry (FCM) is clearly the “gold standard” for
the enumeration of different lymphocyte populations and to follow different aspects of HIV+
patients [8–10], but typically this technique is very expensive and requires sophisticated equip-
ment and trained personnel. In most cases, another expensive instrument, i.e., a hematology an-
alyzer, is required for the absolute cell count. In addition, the lack of ready access to technical
support and quality assurance programs limits the use of FCM in resource-constrained coun-
tries. In the last decade, several single flow platform instruments able to identify and count cells
have been developed. These are mainly represented by flow cytometers that count the absolute
CD4 cell number in a fixed volume, such as CyFlowSL BlueH, CyFlow GreenH, CyFlow Coun-
terH (Partec GmbH, Münster, Germany), Guava EasyCD4 (Guava Technologies, Hayward,
CA), Apogee Auto40 (Apogee Flow Systems, Hemel Hempstead, UK) [11]. These instruments
are much less expensive and easier to perform than those based upon dual platform technology,
or than those that require bead-assisted calibrations and reagents that require the cold chain.
More recently, it became clear that the fight against HIV/AIDS requires point-of-care
(POC) technologies for rapid, reliable and affordable CD4+ analysis, to be used especially in
rural areas [12]. These instruments are designed for minimal operator intervention; among
them, there are a few modified flow cytometers such as the PointCare NOW (PointCare Tech-
nologies, Marlborough, MA, USA) and the CyFlow MiniPOC (Partec), or instruments that
count cells utilizing dual-fluorescence image analysis such as Alere Pima CD4 (Alere Inc, Wal-
tham, MA, USA) [13].
The CyFlow MiniPOC is a portable flow cytometer specifically designed for the automatic
calculation of CD4+ T cell count and percentage. It is equipped with a 30 mW, 532 nm laser
and three optical parameters for the detection of side scatter, orange and red fluorescence. It is
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a True Volumetric Absolute Counting instrument based on the precise counting and mechani-
cal fluid volume measurement, that no need for reference sample or reference beads. It is re-
markable that this instrument can be equipped with a rechargeable lithium battery dock or
with solar panel. The CyFlow MiniPOC can be associated with a kit containing dry lyophilized
reagents (the “CD4% Count Kit-Dry”) such as fluorochrome-conjugated monoclonal antibod-
ies (mAbs), to avoid the cold chain.
Starting form whole blood, results concerning the CD4+ T cell count can be obtained in a
relatively short time (typically, within 20 minutes from the venipuncture), so that the patient
can receive this information before the visit by the clinician and the relative decision-making
process. This has an extraordinary importance in rural areas. However, data are required that
compare this system to those used for routine CD4+ T cell count by the more sophisticated
standard of care systems.
In this study, we aimed to evaluate the accuracy of the CyFlow miniPOC instrument by
comparing data obtained with this system, coupled with the “CD4% Count Kit-Dry” with
those obtained by using two different reference systems suited for CD4 absolute and CD4 per-
cent analysis on whole blood. Moreover, our study also aimed at evaluating the precision of the
instrument, in particular in the presence of low CD4+ count and percentage, and the analysis
of the effects of sample carry over contamination.
Materials and Methods
Patients and blood collection
The study was approved by the Institutional Review Board of the Dept. of Surgery, Medicine,
Dentistry and Morphological Sciences of the University of Modena and Reggio Emilia, and has
been performed in accordance with the ethical standards of the committee on human experi-
mentation and the Helsinki Declaration. After written informed consent, a 3 mL sample of ve-
nous blood was collected in EDTA tubes from 59 HIV+ patients at the time of their routine
visits for the CD4+ T cell count and quantification of plasma viral load. All patients were fol-
lowed by the Infectious and Tropical Diseases Clinics of the University of Modena and Reggio
Emilia (Northern Italy). The study population consisted of 59 HIV+ patients (16 females and
43 males) who were over 18 years of age (range 25–58 years). All but 2 were being treated with
successful combination antiretroviral therapy.
CD4+ T cell count and percentage analysis
Twenty µL of whole blood were stained with the “CD4% Count Kit-Dry” (Partec GmbH—a Sys-
mex Company, Münster, Germany) for the determination of CD4+ T cell count and percentage
by the CyFlowMiniPOC instrument. In parallel, 20 µL of whole blood from the same patients
were stained with the “CD4 Easy Count Kit” (for the determination of CD4+ T cell count) and
the “CD4% Easy Count Kit” (for the determination of CD4+ T cell count and percentage) and
analyzed by CyFlow Counter. All samples were stained and analyzed within 2 hours and all mea-
sures were performed in triplicate. Parallel blood samples were analyzed by the BLU Laboratory
(Unified Laboratory of Baggiovara) that routinely counts CD4+ T cells by a dual platform sys-
tem based upon Cytomics FC 500 (Cytostat tetrachrome kit, for the percentage of CD4+ cell)
and Coulter HmXHematology Analyzer (for the absolute lymphocyte count).
CyFlow MiniPOC technical details
Following the preparation of EDTA blood specimen with Partec miniPOC CD4% Count Kit-
dry according to the manufacturer’s instructions, the samples are inserted in the CyFlow
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miniPOC using a syringe. The CyFlow miniPOC sample port uses computer controlled stepper
motor driven actuator so that the final volume injected in the system is accurately calculated
by using the distance defined by the actuator and the specific diameter of the syringe. The main
element of the CyFlow miniPOC Flow Cytometer is a flow cuvette where single blood cell
stream is analysed. This is made of quartz glass, which contains a capillary with a diameter of
250 × 350 µm.
The fluidic system of the CyFlow miniPOC is used to transport blood cells from a three di-
mensional sample suspension to an orderly single cell stream passing through one illuminating
laser beam. By regulating the air pressure the fluidic system ensures stable operation and it con-
sists of a sheath fluid line and a sample line feeding into the flow cell. The CyFlow miniPOC is
equipped with is equipped with 30 mW 532 nm laser and three optical parameters for the de-
tection of side scattered light (SSC), orange (FL2) and red fluorescence (FL3). The side scat-
tered light and the fluorescence light are collected at an angle of 90° degrees. The light is then
subdivided into different wavelengths by optical filters. In the next step, the photomultiplier
collect the different wavelengths by generating an electronic impulse. The instrument is trig-
gered when this signal exceeds a predefined threshold level. The threshold is primarily used to
reject non—cellular events such as debris or noise from optical and electronic sources. The
data are displayed as 2-parameter dot plot and as digital numbers for both CD4 absolute count
and CD4% values. Additional information are provided in Supplementary Material Section.
Precision assessment
For the repeatability study we choose a whole blood sample with low CD4 absolute count, i.e.
<300 CD4+ T cells/μl. The sample was stained 10 times individually according to the product
data sheet of the “CD4% Count Kit—Dry” designed for the CyFlow MiniPOC. For bulk analy-
sis, the sample was stained 12 times individually. After addition of Buffer 1, all 12 samples were
pooled, carefully mixed and ten aliquots with a volume of 430 µL were transferred into CyFlow
miniPOC tubes. Buffer 2 was added right before analysis of the stained blood samples as de-
scribed in the Operating Manual.
Carry-over contamination analysis
For the carry-over study, 3 whole blood samples were chosen which differed significantly in
their CD4 count value: low CD4 count, defined as<300 CD4+ T cells/μL, medium CD4 count,
defined as 300–600 CD4+ T cells/μL and high CD4 count, defined as>600 CD4+ T cells/μL.
Whole blood samples were stained according to the product data sheet of the CyFlow miniPOC
CD4% Count Dry Kit and the analyses were performed in triplicate with the subsequent order:
medium—high—low—medium—medium—low—low—high—high—medium.
Statistical analysis
The data obtained by test and reference system were compared using correlation coefficient and
linear regression analysis. The CD4+ T-cell count (or CD4% value) obtained by the reference
system was plotted on the x-axis against the CD4+ T-cell count (or CD4% value) obtained by
the test system on the y-axis. Bland-Altman plots were used to evaluate the agreement between
two methods by plotting the mean of the values on the x-axis and the difference of the values on
the y-axis [14]. Precision expressed as the coefficient of variation (CV) was determined by divid-
ing the standard deviation (SD) of the 10 measurements by the mean (%CV = SDx100/mean).
Non parametric Mann-Whitney test was used to compare values from the same sample in the
setting of the carry-over contamination analysis. All the above-mentioned statistical analyses
were performed by Prism 5.0 (GraphPad, La Jolla, CA) software.
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Results
Comparison between CyFlow MiniPOC and CyFlow Counter
The values of CD4+ T cell count obtained by CyFlow MiniPOC showed a very good correlation
with those obtained with the CyFlow Counter either by using the “CD4 Easy Count Kit”
(Fig. 1A; R2 = 0.963, correlation coefficient 0.98) or by using the “CD4% Easy Count Kit”
Figure 1. Comparison of the CyFlowMiniPOC and CyFlow Counter. Correlation and R2 values for CD4+
T cell counts obtained by Cyflow MiniPOC and CyFlow Counter by using the CD4 easy count kit (A) and the
CD4% easy count kit (B).
doi:10.1371/journal.pone.0116848.g001
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(Fig. 1B; R2 = 0.979, correlation coefficient 0.99). The Bland-Altman plot indicates that the
overall, absolute CD4+ T cell counts obtained by the two methods were in excellent agreement
(Fig. 2A and 2B). The values of CD4+ T cell percent obtained by CyFlow MiniPOC showed a
strong correlation with those obtained with the CyFlow Counter by using the CD4% easy
count kit (Fig. 3A; R2 = 0.976, correlation coefficient 0.99). All individual data points repre-
sented in Figs. 1–3 are shown in S1 Table.
Figure 2. Comparison of the CyFlowMiniPOC and CyFlow Counter. Bland-Altman plot comparing
absolute CD4+ T cell counts obtained by Cyflow MiniPOC and CyFlow Counter by using the CD4 easy count
kit (A) and the CD4% easy count kit (B).
doi:10.1371/journal.pone.0116848.g002
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Comparison between CyFlow MiniPOC and dual platform Coulter
FC500
The data obtained by CyFlow MiniPOC display a good correlation with those obtained with
the Coulter FC500 either considering CD4+ T cell count (Fig. 4A; R2 = 0.962, correlation
Figure 3. Comparison of the CyFlowMiniPOC and CyFlow Counter. Linear Regression(A) and Bland-
Altman Plot (B) for CD4+ T cell percent obtained by Cyflow MiniPOC and CyFlow Counter by using the
CD4% easy count kit.
doi:10.1371/journal.pone.0116848.g003
Accurate Analysis of CD4+ Count and Percentage by CyFlowMiniPOC
PLOSONE | DOI:10.1371/journal.pone.0116848 January 26, 2015 7 / 15
coefficient 0.98) either considering CD4+ T cell percentage (Fig. 4B; R2 = 0.941, correlation co-
efficient 0.97). The Bland-Altman plot shows that in both case the two methods were in close
agreement (Fig. 5A and 5B). All individual data points represented in Figs. 4 and 5 are shown
in S2 Table.
Figure 4. Comparison of the CyFlowMiniPOC and BC FC 500.Correlation and R2 values for CD4+ T cell
count (A) and percentage (B) obtained by Cyflow MiniPOC and BC FC 500 reference system.
doi:10.1371/journal.pone.0116848.g004
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Precision assessment
The mean and the coefficient of variation (CV) of CD4 absolute count, obtained with the
CyFlow MiniPOC, was 193 CD4+ T cells/μL and 4.4% for the sample analyzed in single mode,
and 187 CD4+ T cells/μL and 1.4% for the sample analyzed in bulk (Fig. 6A). The mean and
the CV of CD4% was 19% and 4.2%, respectively, for the sample analyzed in single mode, and
18% and 2.8% for the sample analyzed in bulk (Fig. 6B). All individual data points represented
in Fig. 6 are shown in S3 Table.
Figure 5. Comparison of the CyFlowMiniPOC and BC FC 500. Bland-Altman plot comparing absolute
CD4+ T cell count (A) and percentage (B) obtained by Cyflow MiniPOC and BC FC 500 reference system
doi:10.1371/journal.pone.0116848.g005
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Carry-over contamination analysis
As shown in Fig. 7, using the CyFlow MiniPOC, we observed no significant differences among
all samples with low CD4 count and percentage, all those with medium CD4 count and per-
centage and all those with high CD4 count and percentage, regardless of their position in the
sequence of analysis. All individual data points represented in Fig. 7 are shown in S4 Table.
Figure 6. Precision assessment. Bar charts with error bars indicating the standard deviation of CD4 T cell
count (A) and CD4% (B) of a sample analyzed 10 times in single or in bulk. CV = Coefficient of variation.
doi:10.1371/journal.pone.0116848.g006
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Discussion
Highly effective antiretroviral therapy has dramatically decreased the mortality of HIV infec-
tion and significantly prolonged the survival of patients [15, 16], who now have a life expectan-
cy very close to that of non-infected individuals [17]. However, either the initiation of therapy
or the analysis of its efficacy depend on the evaluation of laboratory parameters such as CD4+
T cell count, and indeed a strong debate exist that concerns, for example, the number of CD4+
T cells at which therapy has to start [18]. As a consequence, measuring such cells, along with
the plasma viral load, is absolutely crucial and has a pivotal importance for an optimal manage-
ment of HIV+ patients.
More than 95% of infections occur in low and middle-income countries, where the number
of laboratories that can use sophisticated molecular biology techniques is extremely low. Thus,
even if nowadays molecular virology has fantastic technological possibilities, the quantification
Figure 7. Carry-over contamination analysis. The CD4 absolute count (A) and CD4% (B) were plotted as
the mean value of three analysis sequences. Error bars indicate the standard deviation of
three measurements.
doi:10.1371/journal.pone.0116848.g007
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of plasma viral load is still far from being a test that has a large use. Thus, the simple (and old)
CD4+ T cell count remains the main option to adequately follow a HIV+ patient in resource-
constrained countries [19].
Currently, the gold standard for CD4+ T cell count is a test that requires at least 3 or 4 (if
not more) mAbs conjugated with different fluorochromes, whose binding to peripheral blood
cells is analyzed on a flow cytometer often equipped with 2 lasers. For several years, different
groups, including ours, have largely used multilaser and polychromatic flow cytometry to deep-
ly investigate the immune system during HIV infection [20–24]. Unfortunately, the global cost
of similar instruments, their maintenance and the required reagents cannot realistically be
Figure 8. Partec CyFlowMiniPOC. The Partec CyFlowMiniPOC counting device (A) and its display (B) in
routine (left) or expert mode (right). Both images are used with permission of Partec/Sysmex GmbH,
Germany.
doi:10.1371/journal.pone.0116848.g008
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afforded outside clinics or hospitals with medium to high budgets. Moreover, flow cytometers
that provide excellent measurements along with several additional immunological information
(e.g. the number of CD8+ T cells or T cell activation), are not transportable, nor they can be
used as core instruments where skilled operators able to run, maintain and repair, as well as
trained personnel able to interpret complex data, are not present.
Most HIV+ patients live far from hospital, and do not have the possibility to travel to distant
clinics—or they cannot do this for social reasons, i.e. they do not want to show that they have
to go regularly to the hospital for CD4+ T cell count, that means that they have HIV infection.
Thus, the need for a reliable and economic point of care (POC) diagnostic for the count of
CD4+ T cells is a fundamental tool in the fight against HIV/AIDS. Recently, a panel of WHO
experts have prepared guidelines for the use of POC diagnostics in resource limited environ-
ments, that go under the acronym of ASSURED. The criteria that were identified are related to
the fact that every tool has to be economically Affordable, Sensitive, Specific, User-friendly, Ro-
bust and rapid, Equipment-free, Deliverable [25]. Furthermore, for obvious reasons linked to
the logistics and weather temperatures, it is crucial that the reagents, and in particular fluoro-
chrome-conjugated mAbs, do not require the cold chain.
The main aim of our study was to compare a system that fulfills the ASSURED criteria, such
as that formed by the CyFlow MiniPOC and the CD4% Count Dry-Kit (shown in Fig. 8A),
with the gold standard, dual platform system that is routinely used in an Italian Hospital since
several years, and with another single-platform low cost system, i.e. the CyFlow Counter. We
found that the results obtained with the CyFlow miniPOC with the use of the CD4% count dry
kit are comparable either to those obtained with an independent reference system, i.e. the Beck-
man Coulter FC500 plus Coulter HmX, or to the single platform CyFlow Counter. Further-
more, the results obtained with the dry kits designed for the CyFlow miniPOC were fully
comparable with the liquid kits “CD4 easy count kit” and “CD4% easy count kit” used with the
CyFlow Counter.
In our hands, the CyFlow miniPOC showed an excellent repeatability using whole blood
samples with low CD4 absolute and CD4 percent values, and indeed the assay precision was
below +5% deviation. Finally, the CyFlow miniPOC showed no carry-over contamination
among samples. Thus, the cost-effective and portable instrument CyFlow MiniPOC is able to
produce rapid, reliable and accurate results that are fully comparable with highly expensive
dual platform systems, and allows to analyze a large number of samples per day.
As far as HIV+ adults are concerned, the guidelines indicate to consider the absolute
number of CD4+ T cells to monitor the infection. Here we show that this system is extremely
reliable and provides the same results obtained with instruments that are extremely more ex-
pensive and complex. In HIV+ children, it is important to measure also the percentage of
CD4+ lymphocytes. The assay we used is based upon the staining of whole blood with both
anti-CD4 and anti-CD45 mAbs. CD45 is expressed on the plasma membrane of all
leukocytes, but with a different intensity, that depends on the cell type. Thus, lymphocytes
can be easily recognized on the bases of the side scatter and CD45 expression can be electroni-
cally gated, and the percentage of those expressing CD4 can be easily calculated. Such
operation can be run either in “expert mode”, where the operator can decide what to do, or
in “routine mode”, where the gates are fixed and there is no need of any expert intervention
(see Fig. 8B).
A last but not least consideration is finally required. The quality of CD4+ T cell count ob-
tained by the system we have tested is fully comparable to the current standard of care. Thus,
due to the continuous cuts of budgets that we are experiencing, an accurate and extremely low
cost assay for CD4+ T cell count can be used also by sophisticated laboratories in resource “for
the moment not so poor” settings.
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